GALMED PHARMACEUTICALS LTD. Payments for (Proceeds from) Available-for-sale Securities, Short-term
GALMED PHARMACEUTICALS LTD. (GLMD) reported Payments for (Proceeds from) Available-for-sale Securities, Short-term of $1.57 million for the 6-month period ending 2026-06-30, per its 6-K filed 2026-09-02.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsForProceedsFromAvailableforsaleSecuritiesShortterm · last filed 2026-09-02
- GALMED PHARMACEUTICALS LTD. payments for (proceeds from) available-for-sale securities, short-term for the quarter ending 2025-09-30 was $3.00K, a 99.84% decline year-over-year.
- GALMED PHARMACEUTICALS LTD. payments for (proceeds from) available-for-sale securities, short-term for the quarter ending 2024-09-30 was $1.82M.
| Period end | Payments for (Proceeds from) Available-for-sale Securities, Short-term 3 month | Payments for (Proceeds from) Available-for-sale Securities, Short-term 6 month | Payments for (Proceeds from) Available-for-sale Securities, Short-term 9 month |
|---|---|---|---|
| 2026-06-30 | $1.57M 6-K · filed 2026-09-02 | ||
| 2025-09-30 | $3.00K derived: 6-K 9 month − 6-K 6 month · filed 2025-11-26 | $1.69M 6-K · filed 2025-11-26 | |
| 2025-06-30 | $1.69M 6-K · filed 2026-09-02 | ||
| 2024-09-30 | $1.82M derived: 6-K 9 month − 6-K 6 month · filed 2025-11-26 | $3.33M 6-K · filed 2025-11-26 | |
| 2024-06-30 | $1.51M 6-K · filed 2025-08-28 | ||
| 2023-06-30 | $3.22M 6-K · filed 2024-08-28 | ||
| 2022-06-30 | -$10.46M 6-K · filed 2023-08-09 |